These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1957291)

  • 21. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007.
    Ventura M; Ventura R; Pichini S; Leal S; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Nov; 182(1-3):35-40. PubMed ID: 19004584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of zopiclone in many drivers--a sign of misuse or abuse].
    Bramness JG; Skurtveit S; Mørland J
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2820-1. PubMed ID: 10494203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Toxicological screening of medicines and drugs of abuse in emergency cases].
    Helland A; Espnes KA; Reimers A; Aamo T; Zahlsen K; Rygnestad T; Spigset O
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):42-5. PubMed ID: 18183057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunochemical screening: manipulation, handling and interpretation errors, exemplified by benzodiazepines].
    Schütz H; Verhoff MA; Erdmann F; Weiler G
    Arch Kriminol; 2003; 212(5-6):141-50. PubMed ID: 14723121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Forensic toxicological application of TOXI-LAB screening for biological specimens in autopsy cases and emergency cares].
    Nishigami J; Ohshima T; Takayasu T; Kondo T; Lin Z; Nagano T
    Nihon Hoigaku Zasshi; 1993 Oct; 47(5):372-9. PubMed ID: 8258901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary adulterants and drugs-of-abuse testing.
    Dasgupta A
    MLO Med Lab Obs; 2003 Feb; 35(2):26-8, 30-1. PubMed ID: 12624874
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs in injured drivers in Denmark.
    Bernhoft IM; Steentoft A; Johansen SS; Klitgaard NA; Larsen LB; Hansen LB
    Forensic Sci Int; 2005 Jun; 150(2-3):181-9. PubMed ID: 15944058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica (Ephedraceae))].
    Nishiguchi M; Kinoshita H; Higasa K; Taniguchi T; Ouchi H; Minami T; Marukawa S; Yoshinaga K; Yamauchi J; Aoki S; Hishida S
    Nihon Hoigaku Zasshi; 2001 Nov; 55(3):331-8. PubMed ID: 11905042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hair analysis of abused and therapeutic drugs in forensic toxicology].
    Klausz G; Kass K; Sótonyi P; Róna K
    Orv Hetil; 2006 Nov; 147(45):2181-6. PubMed ID: 17402212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor.
    Fucci N; De Giovanni N; De Giorgio F; Liddi R; Chiarotti M
    Forensic Sci Int; 2006 Jan; 156(2-3):102-5. PubMed ID: 16410159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alleged drug facilitated sexual assault (DFSA) in Northern Ireland from 1999 to 2005. A study of blood alcohol levels.
    Hall J; Goodall EA; Moore T
    J Forensic Leg Med; 2008 Nov; 15(8):497-504. PubMed ID: 18926501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on the abused drugs in saliva and correlation of saliva drugs concentrations with blood concentrations].
    Li PW; Wang YJ; Liu JF
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):309-11, 315. PubMed ID: 17896529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmortem toxicology of drugs of abuse.
    Drummer OH
    Forensic Sci Int; 2004 Jun; 142(2-3):101-13. PubMed ID: 15172074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.